Schilke Tobin
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) · Chief Financial Officer
Schilke Tobin is listed in public filings as officer: Chief Financial Officer. This Schilke Tobin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX), and Revance Therapeutics, Inc. - Common Stock (RVNC). Investors use Schilke Tobin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $3.1M78.1k shares | SellMar 3, 2026 | $266.3K6.7k shares | $39.67 | -- |